Skip to main content
. 2025 Jun 29;14(7):657. doi: 10.3390/antibiotics14070657
AMR antimicrobial resistance
AMC amoxicillin–clavulanic acid
AMK amikacin
AMX amoxicillin
AST antimicrobial susceptibility testing
BSI bloodstream infections
CAZ ceftazidime
CDC Centers for Disease Control and Prevention
CIP ciprofloxacin
CTX cefotaxime
COL colistin
EUCAST European Committee on Antimicrobial Susceptibility Testing
ESBLs extended-spectrum β-lactamases
ETP ertapenem
FEP cefepime
FOS fosfomycin
FOX cefoxitin
GEN gentamicin
GNBs Gram-negative bacteria
IAI intra-abdominal infections
IMP imipenem
IQC internal quality control
LART L’AntibioRésistance en Tunisie
MEM meropenem
MDR multidrug-resistant
NAL nalidixic acid
PIP piperacillin
RTIs respiratory tract infections
SXT trimethoprim–sulfamethoxazole
TIC ticarcillin
TIM ticarcillin–clavulanic acid
TZP piperacillin-tazobactam
UTIs urinary tract infections
3GCs 3rd-generation cephalosporins